NCT00939237View on ClinicalTrials.gov

Trial of Lycopene/Ateronon for Secondary Prevention of Coronary Heart Disease

PHASE3CompletedINTERVENTIONAL
Enrollment

213

Participants

Timeline

Start Date

July 31, 2009

Primary Completion Date

May 31, 2011

Study Completion Date

May 31, 2011

Conditions
Coronary Heart Disease
Interventions
DRUG

Ateronon

7 mg lycopene dietary supplement supplied as one Ateronon capsule taken daily

DRUG

Placebo

Trial Locations (1)

02115

Brigham and Women's Hospital, Boston

Sponsors
All Listed Sponsors
collaborator

CamNutra Ltd.

INDUSTRY

collaborator

Cambridge Theranostics Ltd

INDUSTRY

lead

Brigham and Women's Hospital

OTHER

NCT00939237 - Trial of Lycopene/Ateronon for Secondary Prevention of Coronary Heart Disease | Biotech Hunter | Biotech Hunter